Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Poppits LLC currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is being reviewed by a distinct examiner within 1 distinct art unit. Such a focused portfolio indicates that the company is currently engaged in a very specific prosecution path without broader departmental overlap.
The busiest examiner assigned to the portfolio is VIGIL, TORIANA NICHOLE, who is handling 1 pending office action. Since this examiner is responsible for the entirety of the company's pending workload, the prosecution outcome is currently dependent on this point of contact. This concentration allows for a highly targeted response strategy tailored to the specific requirements of this official.
The presence of a single art unit further simplifies the administrative landscape for Poppits LLC. With the pending office action as the only active metric, the company maintains a low-volume but highly specific presence in the biotechnology sector. Future filings would be required to diversify the examiner and art unit exposure beyond these current levels.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| VIGIL, TORIANA NICHOLE | 1 | 52.9% | +26.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18678792 | SINGLE DOSE ORAL HYGIENE UNIT OF TOOTHPASTE COMPOSITION AND METHOD OF MANUFACTURE | VIGIL, TORIANA NICHOLE | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18678792 | SINGLE DOSE ORAL HYGIENE UNIT OF TOOTHPASTE COMPOSITION AND METHOD OF MANUFACTURE | VIGIL, TORIANA NICHOLE | 1612 | §103 | Final Rejection | — | Pending | May 30, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPoppits LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Toriana Nichole Vigil has the most, with 1 of Poppits LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.